Annovis Bio Ownership 2024 | Who Owns Annovis Bio Now?


OverviewForecastFinancialsChart

Institutional Ownership

9.26%

Insider Ownership

21.56%

Retail Ownership

69.17%

Institutional Holders

49.00

Annovis Bio Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LMR PARTNERS LLP5.38%0.03%572,100-259,300-31.19%3,295,296Jun 30, 2024
VANGUARD GROUP INC3.40%-361,3543,4120.95%2,081,399Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC1.51%0.02%160,30093,100138.54%923,328Jun 30, 2024
ALTIUM CAPITAL MANAGEMENT LP1.46%0.36%155,300155,300100.00%894,528Jun 30, 2024
CAPTION MANAGEMENT, LLC1.18%0.01%125,000-31,500-20.13%720,000Jun 30, 2024
BLACKROCK INC.0.95%-100,7093,0803.15%580,083Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.0.94%0.00%100,000-150,000-60.00%576,000Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.72%-76,2335,4427.69%439,199Jun 30, 2024
TORNO CAPITAL, LLC0.49%0.01%52,50052,500100.00%302,400Jun 30, 2024
WESCOTT FINANCIAL ADVISORY GROUP, LLC0.39%0.03%41,607--239,656Jun 30, 2024
GTS SECURITIES LLC0.38%0.00%40,200-28,300-41.31%231,552Jun 30, 2024
HAP TRADING, LLC0.38%0.00%40,000-14,100-26.06%15,000Jun 30, 2024
STERLING INVESTMENT ADVISORS, LTD.0.32%0.05%33,474-900-2.62%192,810Jun 30, 2024
MODERA WEALTH MANAGEMENT, LLC0.29%0.00%30,513--175,755Jun 30, 2024
STATE STREET CORP0.27%-29,135--167,818,000Jun 30, 2024
UBS GROUP AG0.24%-25,00025,000100.00%144,000Jun 30, 2024
SQUAREPOINT OPS LLC0.24%0.00%25,000--144,000Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.21%0.00%22,100-11,500-34.23%127,296Jun 30, 2024
MERIT FINANCIAL GROUP, LLC0.20%0.00%21,700-500-2.25%124,992Jun 30, 2024
XTX TOPCO LTD0.19%0.01%19,90719,907100.00%114,664Jun 30, 2024

Annovis Bio's largest institutional shareholder is LMR PARTNERS LLP, holding 5.38% of the company's total share outstanding, currently valued at $3.30M. The top 10 institutional shareholders own together 16.42% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
IKARIAN CAPITAL, LLC0.05%0.55%5,517-246,383-97.81%3,177,792Jun 30, 2024
ALTIUM CAPITAL MANAGEMENT LP1.46%0.36%155,300155,300100.00%894,528Jun 30, 2024
STERLING INVESTMENT ADVISORS, LTD.0.32%0.05%33,474-900-2.62%192,810Jun 30, 2024
IKARIAN CAPITAL, LLC0.00%0.05%517-249,483-99.79%297,792Jun 30, 2024
LOKKEN INVESTMENT GROUP LLC0.12%0.03%12,235--70,474Jun 30, 2024
WESCOTT FINANCIAL ADVISORY GROUP, LLC0.39%0.03%41,607--239,656Jun 30, 2024
LMR PARTNERS LLP5.38%0.03%572,100-259,300-31.19%3,295,296Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC1.51%0.02%160,30093,100138.54%923,328Jun 30, 2024
TORNO CAPITAL, LLC0.49%0.01%52,50052,500100.00%302,400Jun 30, 2024
CAPTION MANAGEMENT, LLC1.18%0.01%125,000-31,500-20.13%720,000Jun 30, 2024
XTX TOPCO LTD0.19%0.01%19,90719,907100.00%114,664Jun 30, 2024
GREENWICH WEALTH MANAGEMENT LLC0.14%0.01%15,0752,50019.88%87,000Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.21%0.00%22,100-11,500-34.23%127,296Jun 30, 2024
MERIT FINANCIAL GROUP, LLC0.20%0.00%21,700-500-2.25%124,992Jun 30, 2024
MODERA WEALTH MANAGEMENT, LLC0.29%0.00%30,513--175,755Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC0.13%0.00%13,600-53,100-79.61%78,336Jun 30, 2024
OPAL WEALTH ADVISORS, LLC0.01%0.00%1,0001,000100.00%5,760Jun 30, 2024
SPEARS ABACUS ADVISORS LLC0.14%0.00%15,000--86,400Jun 30, 2024
HAP TRADING, LLC0.38%0.00%40,000-14,100-26.06%15,000Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.0.94%0.00%100,000-150,000-60.00%576,000Jun 30, 2024

The largest Annovis Bio shareholder by % of total assets is IKARIAN CAPITAL, LLC. The company owns 5.52K shares of Annovis Bio (ANVS), representing 0.55% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ALTIUM CAPITAL MANAGEMENT LP1.46%0.36%155,300155,300100.00%894,528Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC1.51%0.02%160,30093,100138.54%923,328Jun 30, 2024
TORNO CAPITAL, LLC0.49%0.01%52,50052,500100.00%302,400Jun 30, 2024
UBS GROUP AG0.24%-25,00025,000100.00%144,000Jun 30, 2024
XTX TOPCO LTD0.19%0.01%19,90719,907100.00%114,664Jun 30, 2024
UBS GROUP AG0.12%-12,99012,3902065.00%74,822Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.72%-76,2335,4427.69%439,199Jun 30, 2024
BELVEDERE TRADING LLC0.04%-4,7784,778100.00%27,521Jun 30, 2024
VANGUARD GROUP INC3.40%-361,3543,4120.95%2,081,399Jun 30, 2024
BLACKROCK INC.0.95%-100,7093,0803.15%580,083Jun 30, 2024
GREENWICH WEALTH MANAGEMENT LLC0.14%0.01%15,0752,50019.88%87,000Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.06%0.00%6,8582,06042.93%39,502Jun 30, 2024
OPAL WEALTH ADVISORS, LLC0.01%0.00%1,0001,000100.00%5,760Jun 30, 2024
FMR LLC0.00%-200200100.00%1,152Jun 30, 2024
EVERSOURCE WEALTH ADVISORS, LLC0.00%0.00%8383100.00%773Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.01%-1,275756.25%7,344Jun 30, 2024
STATE STREET CORP0.27%-29,135--167,818,000Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.18%-19,059--109,781Jun 30, 2024
SQUAREPOINT OPS LLC0.24%0.00%25,000--144,000Jun 30, 2024
WR WEALTH PLANNERS, LLC0.00%0.00%150--864Jun 30, 2024

As of Jun 30 2024, Annovis Bio's largest institutional buyer is ALTIUM CAPITAL MANAGEMENT LP. The company purchased 155.30K stocks of ANVS, valued at $894.53K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LMR PARTNERS LLP5.38%0.03%572,100-259,300-31.19%3,295,296Jun 30, 2024
IKARIAN CAPITAL, LLC0.00%0.05%517-249,483-99.79%297,792Jun 30, 2024
IKARIAN CAPITAL, LLC0.05%0.55%5,517-246,383-97.81%3,177,792Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.0.94%0.00%100,000-150,000-60.00%576,000Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC----72,900-100.00%-Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC0.13%0.00%13,600-53,100-79.61%78,336Jun 30, 2024
BELVEDERE TRADING LLC0.04%-4,500-38,800-89.61%25,920Jun 30, 2024
REDMOND ASSET MANAGEMENT, LLC----36,157-100.00%-Jun 30, 2024
GTS SECURITIES LLC0.11%0.00%11,300-32,700-74.32%65,088Jun 30, 2024
CAPTION MANAGEMENT, LLC1.18%0.01%125,000-31,500-20.13%720,000Jun 30, 2024
GTS SECURITIES LLC0.38%0.00%40,200-28,300-41.31%231,552Jun 30, 2024
BELVEDERE TRADING LLC0.14%0.00%14,900-15,600-51.15%85,824Jun 30, 2024
HAP TRADING, LLC0.38%0.00%40,000-14,100-26.06%15,000Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.21%0.00%22,100-11,500-34.23%127,296Jun 30, 2024
NORTHERN TRUST CORP0.18%-19,235-5,032-20.74%110,793,000Jun 30, 2024
QUEST PARTNERS LLC----3,340-100.00%-Jun 30, 2024
MORGAN STANLEY0.05%-5,498-1,658-23.17%31,668Jun 30, 2024
STERLING INVESTMENT ADVISORS, LTD.0.32%0.05%33,474-900-2.62%192,810Jun 30, 2024
MERIT FINANCIAL GROUP, LLC0.20%0.00%21,700-500-2.25%124,992Jun 30, 2024
BANK OF AMERICA CORP /DE/0.05%-5,065-449-8.14%29,174Jun 30, 2024

As of Jun 30 2024, Annovis Bio's biggest institutional seller is LMR PARTNERS LLP. The company sold -0.26M shares of ANVS, valued at $3.30M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ALTIUM CAPITAL MANAGEMENT LP1.46%0.36%155,300155,300100.00%894,528Jun 30, 2024
TORNO CAPITAL, LLC0.49%0.01%52,50052,500100.00%302,400Jun 30, 2024
UBS GROUP AG0.24%-25,00025,000100.00%144,000Jun 30, 2024
XTX TOPCO LTD0.19%0.01%19,90719,907100.00%114,664Jun 30, 2024
BELVEDERE TRADING LLC0.04%-4,7784,778100.00%27,521Jun 30, 2024
OPAL WEALTH ADVISORS, LLC0.01%0.00%1,0001,000100.00%5,760Jun 30, 2024
FMR LLC0.00%-200200100.00%1,152Jun 30, 2024
EVERSOURCE WEALTH ADVISORS, LLC0.00%0.00%8383100.00%773Jun 30, 2024

Annovis Bio's largest new institutional shareholder by number of shares is ALTIUM CAPITAL MANAGEMENT LP, purchased 155.30K shares, valued at $894.53K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
AFFINITY ASSET ADVISORS, LLC----72,900-100.00%-Jun 30, 2024
REDMOND ASSET MANAGEMENT, LLC----36,157-100.00%-Jun 30, 2024
QUEST PARTNERS LLC----3,340-100.00%-Jun 30, 2024
FNY INVESTMENT ADVISERS, LLC----400-100.00%-Jun 30, 2024
YHB INVESTMENT ADVISORS, INC.----85-100.00%-Jun 30, 2024

Annovis Bio's largest sold out institutional shareholder by shares sold is AFFINITY ASSET ADVISORS, LLC, sold -72.90K shares, valued at -, as of undefined.

Annovis Bio Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
BRIDGEWAY FUNDS INC0.01%32,50010,00044.44%Mar 28, 2024
VANGUARD VALLEY FORGE FUNDS0.01%4,100--Mar 31, 2024
BNY Mellon Strategic Funds, Inc.0.01%15,506--Mar 31, 2024
ETFis Series Trust I0.00%2,387--Jan 31, 2024
VANGUARD INDEX FUNDS0.00%340,805-85,524-20.06%Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%62,84815,53332.83%Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%4,800--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%4,518--Mar 31, 2024
Principal Exchange-Traded Funds0.00%913--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%2,061--Jan 31, 2024
Dimensional ETF Trust0.00%9,714--Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%8,428--Jan 31, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%22,331--Dec 31, 2023
NATIONWIDE MUTUAL FUNDS0.00%776776-Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.00%693--Jan 31, 2024
iSHARES TRUST0.00%15,8631,74412.35%Mar 31, 2024
EQ ADVISORS TRUST0.00%1,091--Mar 31, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%15,244--Feb 29, 2024

Annovis Bio's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 32.50K shares, compromising 0.01% of its total assets.

Annovis Bio Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2449-3.92%
31 Mar, 245115.91%
31 Dec, 234451.72%
30 Sep, 23293.57%
30 Jun, 232827.27%
31 Mar, 2322-
31 Dec, 2222-
30 Sep, 2222-8.33%
30 Jun, 22244.35%
31 Mar, 2223-20.69%
31 Dec, 2129-19.44%
30 Sep, 2136-35.71%
30 Jun, 215686.67%
31 Mar, 2130150.00%
31 Dec, 20129.09%
30 Sep, 201137.50%
30 Jun, 20814.29%
31 Mar, 207-
31 Mar, 121-

As of 30 Jun 24, 49 institutions are holding Annovis Bio's shares, representing a decrease of -3.92% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 24984,303-19.54%
31 Mar, 241,223,3311.56%
31 Dec, 231,204,4928.33%
30 Sep, 231,111,900-13.05%
30 Jun, 231,278,74170.00%
31 Mar, 23752,2021.52%
31 Dec, 22740,9070.43%
30 Sep, 22737,704-4.25%
30 Jun, 22770,423-13.39%
31 Mar, 22889,559-20.29%
31 Dec, 211,116,019-2.16%
30 Sep, 211,140,634-10.12%
30 Jun, 211,269,04352.09%
31 Mar, 21834,4149.80%
31 Dec, 20759,911140.82%
30 Sep, 20315,55129.41%
30 Jun, 20243,84326.22%
31 Mar, 20193,186-
31 Mar, 1217,411-

Annovis Bio (ANVS) has 984.30K shares outstanding as of 30 Jun 24, down -19.54% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 249.26%6.99%
31 Mar, 2411.51%7.20%
31 Dec, 2312.64%8.31%
30 Sep, 2312.34%6.05%
30 Jun, 2314.29%16.96%
31 Mar, 239.18%11.14%
31 Dec, 229.08%11.11%
30 Sep, 229.04%10.15%
30 Jun, 229.44%7.94%
31 Mar, 2210.90%5.09%
31 Dec, 2114.63%7.38%
30 Sep, 2114.08%4.75%
30 Jun, 2117.23%11.85%
31 Mar, 2112.06%8.31%
31 Dec, 2012.04%57.12%
30 Sep, 204.59%36.36%
30 Jun, 203.55%20.15%
31 Mar, 204.20%-
31 Mar, 120.40%-

As of 30 Jun 24, Annovis Bio is held by 9.26% institutional shareholders, representing a 6.99% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2417-41.38%
31 Mar, 242916.00%
31 Dec, 2325177.78%
30 Sep, 239-25.00%
30 Jun, 23129.09%
31 Mar, 231137.50%
31 Dec, 228-
30 Sep, 228-
30 Jun, 228-20.00%
31 Mar, 2210-23.08%
31 Dec, 2113-38.10%
30 Sep, 2121-50.00%
30 Jun, 2142100.00%
31 Mar, 2121320.00%
31 Dec, 205-44.44%
30 Sep, 209125.00%
30 Jun, 204-42.86%
31 Mar, 207-
31 Mar, 121-

17 institutional shareholders have increased their position in ANVS stock as of 30 Jun 24 compared to 29 in the previous quarter (a -41.38% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2414133.33%
31 Mar, 246-14.29%
31 Dec, 237-12.50%
30 Sep, 238100.00%
30 Jun, 234-
31 Mar, 234-20.00%
31 Dec, 225-
30 Sep, 225-37.50%
30 Jun, 22814.29%
31 Mar, 227-22.22%
31 Dec, 219-10.00%
30 Sep, 2110-16.67%
30 Jun, 211271.43%
31 Mar, 217133.33%
31 Dec, 203200.00%
30 Sep, 201-
30 Jun, 201-
31 Mar, 20--
31 Mar, 12--

14 institutional shareholders have reduced their position in ANVS stock as of 30 Jun 24 compared to 6 in the previous quarter (a 133.33% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2449-3.92%984,303-19.54%9.26%6.99%17-41.38%14133.33%
31 Mar, 245115.91%1,223,3311.56%11.51%7.20%2916.00%6-14.29%
31 Dec, 234451.72%1,204,4928.33%12.64%8.31%25177.78%7-12.50%
30 Sep, 23293.57%1,111,900-13.05%12.34%6.05%9-25.00%8100.00%
30 Jun, 232827.27%1,278,74170.00%14.29%16.96%129.09%4-
31 Mar, 2322-752,2021.52%9.18%11.14%1137.50%4-20.00%
31 Dec, 2222-740,9070.43%9.08%11.11%8-5-
30 Sep, 2222-8.33%737,704-4.25%9.04%10.15%8-5-37.50%
30 Jun, 22244.35%770,423-13.39%9.44%7.94%8-20.00%814.29%
31 Mar, 2223-20.69%889,559-20.29%10.90%5.09%10-23.08%7-22.22%
31 Dec, 2129-19.44%1,116,019-2.16%14.63%7.38%13-38.10%9-10.00%
30 Sep, 2136-35.71%1,140,634-10.12%14.08%4.75%21-50.00%10-16.67%
30 Jun, 215686.67%1,269,04352.09%17.23%11.85%42100.00%1271.43%
31 Mar, 2130150.00%834,4149.80%12.06%8.31%21320.00%7133.33%
31 Dec, 20129.09%759,911140.82%12.04%57.12%5-44.44%3200.00%
30 Sep, 201137.50%315,55129.41%4.59%36.36%9125.00%1-
30 Jun, 20814.29%243,84326.22%3.55%20.15%4-42.86%1-
31 Mar, 207-193,186-4.20%-7---
31 Mar, 121-17,411-0.40%-1---

Annovis Bio Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 03, 2024Maccecchini Maria-Luisadirector, 10 percent owner, officer President and CEOG-GiftSell10,000--1,088,459
Jul 03, 2024Maccecchini Maria-Luisadirector, 10 percent owner, officer President and CEOG-GiftSell10,000--1,078,459
Jul 03, 2024Maccecchini Maria-Luisadirector, 10 percent owner, officer President and CEOG-GiftSell10,000--1,068,459

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 03, 2024White Mark K.director-A-AwardBuy26,200$6.07$159.03K26,200
Jul 03, 2024White Mark K.director-A-AwardBuy20,000$5.27$105.40K20,000
Jul 03, 2024White Mark K.director-A-AwardBuy2,146$7.39$15.86K2,146
Jul 03, 2024McCarthy Reiddirector-A-AwardBuy29,600$6.07$179.67K29,600
Jul 03, 2024Maccecchini Maria-Luisadirector, 10 percent owner, officer President and CEOG-GiftSell10,000--1,088,459
Jul 03, 2024Maccecchini Maria-Luisadirector, 10 percent owner, officer President and CEOG-GiftSell10,000--1,078,459
Jul 03, 2024Maccecchini Maria-Luisadirector, 10 percent owner, officer President and CEOG-GiftSell10,000--1,068,459
Jul 03, 2024Maccecchini Maria-Luisadirector, 10 percent owner, officer President and CEOA-AwardBuy252,000$6.07$1.53M252,000
Jul 03, 2024Maccecchini Maria-Luisadirector, 10 percent owner, officer President and CEOA-AwardBuy108,800$6.07$660.42K108,800
Jul 03, 2024Hoffman Michael Bdirector, 10 percent owner A-AwardBuy29,600$6.07$179.67K29,600
Jul 03, 2024Bruck Claudinedirector-A-AwardBuy26,200$6.07$159.03K26,200
Nov 22, 2023White Mark K.director-A-AwardBuy1,990$6.10$12.14K61,167
Nov 22, 2023McCarthy Reiddirector-J-OtherBuy---7,305
Nov 22, 2023Hoffman Michael Bdirector, 10 percent owner A-AwardBuy163,880$6.10$999.67K223,357
Nov 22, 2023Maccecchini Maria-Luisadirector, 10 percent owner, officer President and CEOA-AwardBuy40,970$6.10$249.92K1,098,459
Nov 22, 2023Hagopian Henry IIIofficer Chief Financial OfficerA-AwardBuy820$6.10$5.00K1,820
Nov 22, 2023Bruck Claudinedirector-J-OtherBuy---6,567
Nov 21, 2023McCarthy Reiddirector-A-AwardBuy824$6.07$5.00K8,129
Nov 21, 2023Hoffman Michael Bdirector, 10 percent owner A-AwardBuy164,745$6.07$1.00M224,222
Nov 21, 2023White Mark K.director-A-AwardBuy2,000$6.07$12.14K61,177

The last insider sell of Annovis Bio's stock was made by Maccecchini Maria-Luisa on Jul 03 2024, selling 10,000 shares at - per share (valued at -).

Annovis Bio Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20241--
Q1 2024-3-
Q4 202319--
Q2 202361600.00%
Q1 202371700.00%
Q3 20221--
Q1 2022105200.00%
Q4 20217--
Q3 20217--
Q2 2021-1-
Q3 20204--
Q2 20202--
Q1 2020203655.56%

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Annovis Bio's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q1 2024---
Q4 2023---
Q2 2023---
Q1 2023---
Q3 2022---
Q1 2022---
Q4 20213--
Q3 20211--
Q2 2021---
Q3 2020---
Q2 2020---
Q1 20208--

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Annovis Bio's stocks.

Annovis Bio Peer Ownership


TickerCompany
GRCLGracell Biotechnologies Inc.
CUECue Biopharma, Inc.
AVXLAnavex Life Sciences Corp.
IOVAIovance Biotherapeutics, Inc.
RVPHReviva Pharmaceuticals Holdings, Inc.
DAWNDay One Biopharmaceuticals, Inc.
MCRBSeres Therapeutics, Inc.
TERNTerns Pharmaceuticals, Inc.
INZYInozyme Pharma, Inc.
AXSMAxsome Therapeutics, Inc.
LTRNLantern Pharma Inc.
ABOSAcumen Pharmaceuticals, Inc.
TFFPTFF Pharmaceuticals, Inc.
INABIN8bio, Inc.
SAVACassava Sciences, Inc.
NVAXNovavax, Inc.
ANIXAnixa Biosciences, Inc.
IMNMImmunome, Inc.
GRTXGalera Therapeutics, Inc.

ANVS Ownership FAQ


Annovis Bio is owned by institutional shareholders (9.26%), insiders (21.56%), and public (69.17%). The largest institutional shareholder of Annovis Bio is LMR PARTNERS LLP (5.38% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.01% of total shares).

Annovis Bio's major institutional shareholders are LMR PARTNERS LLP, VANGUARD GROUP INC, BOOTHBAY FUND MANAGEMENT, LLC, ALTIUM CAPITAL MANAGEMENT LP, and CAPTION MANAGEMENT, LLC. The top five shareholders own together 12.93% of the company's share outstanding.

As of Jun 2024, there are 49 institutional shareholders of Annovis Bio.

LMR PARTNERS LLP owns 572.1K shares of Annovis Bio, representing 5.38% of the company's total shares outstanding, valued at $3.3M (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 361.35K shares of Annovis Bio (ANVS), compromising 3.40% of the company, valued at $2.08M.

BOOTHBAY FUND MANAGEMENT, LLC is the third largest holder of Annovis Bio. The company owns 160.3K of the company's shares outstanding (worth $923.33K).